Commercialization: Page 48
-
PharmaVoice Team/PharmaVoice
What's New
Coalition Aims to Help Prevent Abuse and Diversion of ADHD medications Trending Now: Industry stakeholders band together to address medication misuse. The Coalition to Prevent ADHD Medication Misuse (CPAMM) was formed to prevent the misuse, abuse, and diversion of ADHD prescription stimulant medi...
By Ann Grey • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Social Buzz
Engagement Solutions Allow for Better Interactions Trending now: Mobile apps drive interaction across all stakeholder groups Sanofi Adds Texting to BGStar Device Sanofi recently added an automatic texting component to its diabetes management products BGStar and iBGStar that automatically sends a ...
By Taren Grom • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
A New Frontier in Eye Care Jeff George, Global Head of Alcon, talks about the company’s agreement with Google to develop a smart contact lens, which has the potential to transform eye care. Alcon is developing a smart lens technology that includes sensors, microchips, and other miniaturized elec...
By Jeff George • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
UpFront
Imdustry at Large Genzyme Announces Launch of Expression of Hope III Genzyme, a Sanofi company, has launched Expression of Hope III, a global program of inspiration and awareness featuring works of art by the community of people affected by lysosomal storage disorders (LSD). This unique program e...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Collaborating for Success Going it alone when it comes to drug development is a business and R&D model falling out of vogue. The highly competitive and IP-protective pharmaceutical industry is opening its proverbial R&D vaults with the hope that a diverse meeting of the minds and diversit...
By Taren Grom • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
C-Suite: Outsourcing
Outsourcing We asked C-suite executives throughout the outsourcing ecosystem to provide their insights on what the biggest opportunities for innovation are, what are the biggest barriers, and identify a recent innovation that is improving the process. Nick Demling Executive VP Planet Pharma Opp...
By Taren Grom • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Coupling Productivity to Compliance in Customer Communication for Life Sciences
In the digital world, the engagement of a complete collaborative compliance solution is now essential to accelerating process efficiency through review to release, and ultimately for product commercialization. Inefficiency through medical/promotional content review and approval within the li...
By David Bennett • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Storytelling: It's How We Communicate
To engage patients and HCPs, we must focus on the customer journey, not the brand journey. Storytelling is an interesting concept. Think about the last time you were out with friends — every conversation was punctuated by “stories" of our different experiences. It’s how we help people understand ...
By Jay Bolling • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Stepping Up Brand Relevance in the New Age of Healthcare
“The consumer isn’t a moron; she is your wife. You insult her intelligence if you assume that a mere slogan and a few vapid adjectives will persuade her to buy anything. She wants all the information you can give her." David Ogilvy Confessions of an Advertising Man It’s always refreshing to see t...
By Shelagh Brooke • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Planning and Implementing an Effective Non-Personal Promotion Campaign
Non-personal promotion (NPP) is a more effective method of reaching and engaging physicians than the traditional representative-centric model. NPP allows pharma companies to connect with HCPs on cost-effective channels they trust and use regularly, leveraging tactics that seamlessly integrate wi...
By Robert D. Bedford • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
"Big Data" No Longer Just a By-Product of the Healthcare System
The huge increase in high-quality information on patients and their interactions with HCPs is demanding a big shift in our marketing efforts. Marketers must now understand that success isn’t only about generating data — it’s also about generating insights from that data, and then actions from tho...
By Jeff Meehan • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Why Small Ideas are Now The Big Idea
Today’s pharmaceutical marketers need to weave many small ideas to touch each patient at the right place and time. For decades marketers looked at “big idea" and “reach and frequency" as the cornerstones of their campaigns. Today a one-size-fits-all idea repeated at top volume no longer qualifies...
By Boris Kushkuley • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
What Star Wars Teaches Us About Achieving Audience Engagement
The most significant and critical shift in marketing today is in focusing on audience needs and preferences, rather than on the tactical aspects of a campaign. Sometimes pharma marketing can feel like a dramatic saga — there are the good guys, there are the bad guys, there are rebels, people wh...
By Eugene Lee • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Commercial Development in a Complex Environment: Maximizing Future Success
Future planning defines the destination that will best help the company achieve commercial success and then develop the most effective strategy required to arrive at that destination. Importantly, this strategy is as much about determining what not to do as well as what to do. Today’s biopharma c...
By Mike Suesserman • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Physician Employment and the Shift of Influence in Healthcare Delivery
With the delivery of healthcare becoming more consolidated, decision making is now centralized within a group of powerful health systems that oversee complex networks of hospitals, nursing homes, medical offices, and practice groups. Driven by reform, such as the Affordable Care Act, health syste...
By Dave Escalante • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Telling a Complex B2B Story With Two Words
The journey to a complete ad campaign taught us that we need to think differently about ourselves in order to allow our customers to think differently about us. We took a four-phased approach and sought the counsel of agencies partners and perspective from our associates along the way. The averag...
By Andrew Schultz • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Ushering in the E-Patient Era
For the true era of e-patients to arrive, we need to understand where they are on their journey and leverage technology that is both easier and better for them. Has the era of the e-patient really arrived? And by “e-patient," we mean those individuals who actively participate in their health and...
By Emily Tower • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Marketing: Marketing for the Masses
Marketing messages today may be reaching more people through the growing use of technology, at the same time those messages are becoming more personal. Customer-centric messaging, patient engagement, and personalized content are an increasingly important part of the marketing tool kit. As digital...
By Taren Grom • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Innovative Use of Data
As patients adopt digital in their daily lives, the data that are being generated can be utilized — with consent, or in an anonymized manner — to provide a complete view of the patient’s health and well-being, along with how medication can become a part of that overall program. We now live in a d...
By Ritesh Patel • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Renewed Focus on a Longstanding Issue
Data quality management deserves further attention simply because many companies have yet to master it; few companies, in general, seem to have data that meet their quality standards. Life-sciences companies have always sought to manage the quality of their master data — records on customers, pr...
By PharmaVoice Team • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Data Management: A Key Business Driver
With so much data now available, there are a number of opportunities and challenges related to developing actionable insights to drive business success. Big data, smart data, and analytics are key concepts that continue to drive conversations and business decisions throughout the industry and thr...
By Taren Grom • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Stability and Growth Attract Pharma to Chile
Chile is becoming more attractive to global pharmaceutical companies as the market continues to show strong growth. One of the most stable and prosperous countries in South America, Chile has embraced democracy since the dictator General Augusto Pinochet was removed from power in the 1980s. With ...
By Kim Ribbink • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Brand Identity in a Consumer-Driven World
Branding strategies evolve to meet new marketplace demands. Brands are up against new barriers as the control of what product gets prescribed and filled shifts from the physician to the payer and, even more importantly, to the patient. As healthcare consumers claim more and more power over their ...
By PharmaVoice Team • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Digital Patients: Disrupting the Status Quo
Patients have the power of digital technology to fuel their quest for better health, which is forcing the industry to keep pace with their digital needs. Patients’ prolific use of digital technologies to improve their health outcomes is driving other healthcare stakeholders — physicians, payers, ...
By PharmaVoice Team • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool DR. JOHN ORLOFF Baxter Appoints VP of BioScience R&D Baxter International has appointed John Orloff, M.D., as VP and global head of research and development for Baxter BioScience. Dr. Orloff joins Baxter from Merck Serono Pharmaceuticals, where he served as global head of clinical...
By Ann Grey • Aug. 28, 2014
Previous
